HUMIRA
Solution for injection in pre-filled pen, 80mg
RxActive license
Active substance (INN)
adalimumab
Pharmaceutical form
Pharmaceutical formSolution for injection in pre-filled pen
Strength80mg
PackagingUkupno 1 napunjeni injekcioni pen sa 0.8ml rastvora za injekciju u kartonskoj kutiji
ManufacturerAbbVie Biotechnology GmbH, Germany
Therapeutic groupAntineoplastic and immunomodulating agents (L04AB04)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateAugust 7, 2023
Analogs in Montenegro
7Other medicines with the same active substance
HUKYNDRARx
Solution for injection in pre-filled syringe, 40mgHUKYNDRARx
Solution for injection in pre-filled syringe, 80mgHUKYNDRARx
Solution for injection in pre-filled pen, 40mgHUMIRARx
Solution for injection in pre-filled syringe, 20mg/0.2mlHUMIRA®Rx
Solution for injection in pre-filled syringe, 40mg/0.4mlHYRIMOZRx
Solution for injection in pre-filled pen, 40mg/0.8mlHYRIMOZRx
Solution for injection in pre-filled syringe, 40mg/0.8mlSource: CInMED register